Home › Compare › RBWNY vs ABBV
RBWNY yields 1.62% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, RBWNY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RBWNY + ABBV for your $10,000?
Royal Boskalis Westminster N.V. provides dredging, offshore energy, and maritime services worldwide. Its Dredging & Inland Infra segment constructs and maintains ports and waterways; and provides land reclamation, coastal defense, riverbank protection, and underwater rock fragmentation services. This segment also extracts raw materials; designs, prepares, and executes civil infra works, including the construction of roads and railroads, bridges, dams, viaducts, and tunnels; performs specialist works, such as soil improvement and land remediation; and operates as a contractor of dry infrastructure projects. The company's Offshore Energy segment is involved in the engineering, construction, maintenance, and decommissioning of oil and liquefied natural gas import/export facilities, offshore platforms, pipelines and cables, and offshore wind farms. This segment also offers heavy transport, lift and installation work, and diving and remotely operated vehicle services, as well as dredging, offshore pipeline and cable installation, rock installation, and marine activities and survey services. Its Towage & Salvage segment offers towage services to incoming and outgoing oceangoing vessels; and berthing and unberthing of tankers, pilotage, subsea inspection and maintenance, firefighting, and the coupling and uncoupling of terminal connections, as well as operates and manages onshore and offshore terminals. This segment also provides assistance to vessels in distress, shipwrecks or damaged offshore platforms removal, environmental care, and consultancy services. The company primarily serves oil, gas, and wind energy companies; port and terminal operators; governments; shipping and insurance companies; international project developers; and mining companies and related EPC contractors and subcontractors. It operates a fleet of approximately 600 vessels and floating equipment. The company was founded in 1910 and is headquartered in Papendrecht, the Netherlands. As of September 20, 2022, Royal Boskalis Westminster N.V. was taken private.
Full RBWNY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.